ScholarIQanswers from OpenAlex
New England Journal of Medicine
JournalCitation impact & published research
New England Journal of Medicine is a journal indexed in ScholarIQ from OpenAlex.
How many works does New England Journal of Medicine have?
ScholarIQindexed works
New England Journal of Medicine has 191,246 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does New England Journal of Medicine have?
ScholarIQcitation count
New England Journal of Medicine has 12,390,474 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of New England Journal of Medicine?
ScholarIQh-index
New England Journal of Medicine has an h-index of 1,507 in OpenAlex.
What is the OpenAlex record for New England Journal of Medicine?
ScholarIQopenalex
The OpenAlex for New England Journal of Medicine is on the source record.
What are the most-cited papers on New England Journal of Medicine?
ScholarIQmost cited works
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia
Qun Li, Xuhua Guan, Peng Wu, Xiaoye Wang, Lei Zhou, Yeqing Tong, Ruiqi Ren, Kathy Leung, Eric H. Y. Lau, Jessica Y. Wong, Xuesen Xing, Nijuan Xiang, Yang Wu, Chao Li, Qi Chen, Dan Li, Tian Liu, Jing Zhao, Man Liu, Wenxiao Tu, Chuding Chen, Lianmei Jin, Rui Yang, Qi Wang, Suhua Zhou, Rui Wang, Hui Liu, Yinbo Luo, Yuan Liu, Ge Shao, Huan Li, Zhongfa Tao, Yang Yang, Zhiqiang Deng, Boxi Liu, Zhitao Ma, Yanping Zhang, Guoqing Shi, Tommy Tsan‐Yuk Lam, Joseph T. Wu, George F. Gao, Benjamin J. Cowling, Bo Yang, GM Leung, Zijian Feng
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
Suzanne L. Topalian, F. Stephen Hodi, Julie R. Brahmer, Scott Gettinger, David C. Smith, David F. McDermott, John D. Powderly, Richard D. Carvajal, Jeffrey A. Sosman, Michael B. Atkins, Philip D. Leming, David R. Spigel, Scott Antonia, Leora Horn, Charles G. Drake, Drew M. Pardoll, Lieping Chen, William H. Sharfman, Robert A. Anders, Janis M. Taube, Tracee L. McMiller, Haiying Xu, Alan J. Korman, Maria Jure–Kunkel, Shruti Agrawal, D. G. McDonald, Georgia Kollia, Ashok Gupta, Jon M. Wigginton, Mario Sznol
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman, Christoph Wanner, John M. Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J. Woerle, Uli C. Broedl, Silvio E. Inzucchi
Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
Dennis J. Slamon, Brian Leyland‐Jones, Steven Shak, H. Fuchs, Virginia Paton, Alex Bajamonde, Thomas Fleming, W. Eiermann, Janet Wolter, Mark D. Pegram, José Baselga, Larry Norton
Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization
Alan S. Go, Glenn M. Chertow, Dongjie Fan, Charles E. McCulloch, Chi‐yuan Hsu